|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: George E. Cox III |
Date | 10/21/2024 8:26:40 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 6363, Further Continuing Appropriations and Other Extensions Act, 2024, provisions relating to dual intent residents
H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024, provisions relating to Conrad 30 program, and Medicare payments
H. Res. 1102, Further Consolidated Appropriations Act, 2024, provisions relating to Conrad 30 extension
H.R. 9747, Continuing Appropriations and Extensions Act, 2025, provisions relating to continuing resolution through December 20
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 3046, Medical Student Education Authorization Act of 2023, all provisions
S. 1403, Medical Student Education Authorization Act of 2023, all provisions
H.R. 1202, Resident Education Deferred Interest (REDI) Act, all provisions
S. 704, Resident Education Deferred Interest (REDI) Act, all provisions
H.R. 2761, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions
S. 705, Specialty Physicians Advancing Rural Care (SPARC) Act, all provisions
H.R. 7050, Substance Use Disorder Workforce Act, all provisions
H.R. 7258, Community TEAMS Act of 2024, all provisions
S. 3968, Community TEAMS Act of 2024, all provisions
S. 3022, IHS Workforce Parity Act of 2023, all provisions
H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions
S. 1302, Resident Physician Shortage Reduction Act of 2023, all provisions
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 8318, Tribal Tax and Investment Reform Act of 2024, provisions relating to sections 12 and 13
H.R. 4829, Physical Therapist Workforce and Patient Access Act of 2023, all provisions
H.R. 7725, To amend the Higher Education Act of 1965 to prohibit graduate medical schools from receiving Federal financial assistance if such schools adopt certain policies and requirements relating to diversity, equity, and inclusion, all provisions
S. 4115, Embracing anti-Discrimination, Unbiased Curricula, and Advancing Truth in Education (EDUCATE) Act, all provisions
H.R. 8235, Rural Physician Workforce Preservation Act, all provisions
Opioid Workforce Act/draft
Pathways to Practice
GME cap flexibility
GME funding
Liaison Committee on Medical Education
Medical education/Artificial Intelligence (AI)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Defense - Dept of (DOD), Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
Delosh |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 618, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions
S. 131, Improving Access to Workers Compensation for Injured Federal Workers Act of 2023, all provisions
H.R. 2923, Living Donor Protection Act of 2023, all provisions
S. 1384, Living Donor Protection Act of 2023, all provisions
H.R. 1359, Modernizing Opioid Treatment Access Act, all provisions
S. 644, Modernizing Opioid Treatment Access Act, all provisions
H.R. 766, Dr. Michael C. Burgess Preventive Health Savings Act, all provisions
S. 114, Dr. Michael C. Burgess Preventive Health Savings Act, all provisions
H.R. 2630, Safe Step Act, all provisions
S. 652, Safe Step Act, all provisions
S. 113, Prescription Pricing for the People Act of 2023, all provisions
H.R. 7153, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions
S. 3679, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions
S. 2840, Bipartisan Primary Care and Health Workforce Act, all provisions
S. 127, Pharmacy Benefit Manager Transparency Act of 2023, all provisions
H.R. 8325, Physician and Patient Safety Act, all provisions
S. 4278, Physician and Patient Safety Act, all provisions
H.R. 3417, Facilitating Accountability In Reimbursements (FAIR) Act, provisions relating to site neutral payments
H.R. 6033, Supporting Patient Education And Knowledge (SPEAK) Act of 2024, all provisions
H.R. 2411, National Nursing Workforce Center Act of 2023, all provisions
H.R. 6230, Doctor Knows Best Act of 2023, all provisions
S. 4349, A bill to require private health plans to provide for secure electronic transmission of prior authorization requests for prescription drugs, all provisions
H.R. 6881, AI Foundation Model Transparency Act of 2023, all provisions
S. 5271, A bill to require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency, all provisions
H.R. 206, Healthy Technology Act of 2023, all provisions
Supporting Healthy Moms and Babies Act/draft
Dr. Paul Farmer Global Health Training Act/draft
Telehealth/Licensure portability
Telehealth/Reserve Health Readiness Program
South Asians in United States/Cardiovascular disease/high mortality rates
OBGYN data/Georgia
Health information technology/interoperability (HTI-2)
Laboratory developed tests
Telehealth/data needs
Data Privacy and Cybersecurity
Health Insurance Portability and Accountability Act (HIPAA)/electronic records
Mental health parity/addiction equity
CHANGE Healthcare cyberattack
Cybersecurity incident reporting
Nutrition/sodium reduction
Maternal mortality
Reproductive health
Health equity
Digital Health/AI
Misinformation regulation
Medical debt
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), Labor - Dept of (DOL), Treasury - Dept of, Homeland Security - Dept of (DHS), Food & Drug Administration (FDA), Consumer Financial Protection Bureau (CFPB), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Shannon |
Curtis |
|
|
|
Suzanne |
Joy |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Ashley |
Delosh |
|
|
|
Bryan |
Hull |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 4942, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 665, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 6205, Healthcare Workforce Resilience Act, all provisions
S. 3211, Healthcare Workforce Resilience Act, all provisions
H.R. 4875, Doctors in our Borders Act, all provisions
H.R. 6980, Directing Our Countrys Transfer Of Residency Slots (DOCTORS) Act, all provisions
S. 2719, Directing Our Countrys Transfer Of Residency Slots (DOCTORS) Act, all provisions
H.R. 6363, Further Continuing Appropriations and Other Extensions Act, 2024, provisions relating to dual intent residents
H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024, provisions relating to Conrad 30 program
H. Res. 1102, Further Consolidated Appropriations Act, 2024, provisions relating to Conrad 30 extension
H.R. 9747, Continuing Appropriations and Extensions Act, 2025, provisions relating to continuing resolution through December 20
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
S. 3022, IHS Workforce Parity Act of 2023, all provisions
H.R. 8318, Tribal Tax and Investment Reform Act of 2024, provisions relating to sections 12 and 13
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Pharmacy Benefit Manager (PBM) market competition/insurer vertical integration
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 6645, Medicare Audiology Access Improvement Act of 2023, all provisions
S. 2377, Medicare Audiology Access Improvement Act of 2023, all provisions
H.R. 1610, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
S. 799, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
H.R. 4189, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023, all provisions
S. 2016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023, all provisions
H.R. 8532, Connected MOM Act, all provisions
S. 712, Connected MOM Act, all provisions
H.R. 1770, Equitable Community Access to Pharmacist Services Act, all provisions
S. 2477, Equitable Community Access to Pharmacist Services Act, all provisions
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 4968, Getting Over Lengthy Delays in Care As Required by Doctors (GOLD CARD) Act of 2023, all provisions
H.R. 2713, Improving Care and Access to Nurses (I CAN) Act, all provisions
S. 2418, Improving Care and Access to Nurses (I CAN) Act, all provisions
H.R. 2583, Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023, all provisions
H.R. 6487, No Fees for EFTs Act, all provisions
S. 3805, No Fees for EFTs Act, all provisions
H.R. 977, Patient Access to Higher Quality Health Care Act of 2023, all provisions
S. 470, Patient Access to Higher Quality Health Care Act of 2023, all provisions
H.R. 2389, Resident Physician Shortage Reduction Act of 2023, all provisions
S. 1302, Resident Physician Shortage Reduction Act of 2023, all provisions
H.R. 7050, Substance Use Disorder Workforce Act, all provisions
H.R. 7623, Telehealth Modernization Act of 2024, all provisions
H.R. 2474, Strengthening Medicare for Patients and Providers Act, all provisions
H.R. 830, Help Ensure Lower Patient (HELP) Copays Act, all provisions
S. 1375, Help Ensure Lower Patient (HELP) Copays Act, all provisions
H.R. 6371, Provider Reimbursement Stability Act of 2023, all provisions
H.R. 6545, Physician Fee Schedule Update and Improvements Act, all provisions
H.R. 5378, Lower Costs, More Transparency Act, all provisions
H.R. 6683, Preserving Seniors Access to Physicians Act of 2023, all provisions
H.R. 5013, Value in Health Care Act of 2023, all provisions
S. 3503, Value in Health Care Act of 2023, all provisions
H.R. 8702, Improving Seniors Timely Access to Care Act of 2024, all provisions
S. 4532, Improving Seniors Timely Access to Care Act of 2024, all provisions
S. 4518, Improving Seniors Timely Access to Care Act of 2024, all provisions
S. 4935, Physician Fee Stabilization Act, all provisions
H.R. 6366, To amend title XVIII of the Social Security Act with respect to the work geographic index for physician payments under the Medicare program, and to revise the phase-in of clinical laboratory test payment changes under such program, all provisions
H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024, provisions relating to Medicare payments
H.R. 7931, Preserving Emergency Access in Key Sites (PEAKS) Act, all provisions
S. 4338, Pay PCPs Act of 2024, all provisions
H.R. 8563, Preserving Access To Care in Hawaii (PATCH) Act, all provisions
S. 4395, Protecting Access To Care in Hawaii (PATCH) Act, all provisions
H.R. 6369, To amend title XVIII of the Social Security Act to extend incentive payments for participation in eligible alternative payment models, all provisions
H.R. 7665, ACO Assignment Improvement Act of 2024, all provisions
S. 3939, ACO Assignment Improvement Act of 2024, all provisions
H.R. 8404, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2024, all provisions
S. 4330, Radiation Oncology Case Rate (ROCR) Value Based Program Act of 2024, all provisions
H.R. 4829, Physical Therapist Workforce and Patient Access Act of 2023, all provisions
H.R. 8235, Rural Physician Workforce Preservation Act, all provisions
H.R. 1745, Medicare Fraud Detection and Deterrence Act of 2023, all provisions
H.R. 1746, Preventing Medicare Telefraud Act, all provisions
H.R. 8261, Preserving Telehealth, Hospital, and Ambulance Access Act, all provisions
S. 1491, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions
S. 669, Increasing Mental Health Options Act of 2023, all provisions
H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act, all provisions
H.R. 3730, Rural Health Clinic Burden Reduction Act, all provisions
H.R. 7279, Remove Duplicative Unnecessary Clerical Exchanges (REDUCE) Act, all provisions
H.R. 7708, Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act, all provisions
S. 3508, Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act, all provisions
H.R. 9001, Physician Led and Rural Access to Quality Care Act, all provisions
S. 5218, A bill to amend titles XI and XVIII of the Social Security Act to strengthen, increase oversight of, and compliance with, security standards for health information, and for other purposes, all provisions
S. 4054, Health Care Cybersecurity Improvement Act of 2024, all provisions
H.R. 8588, Linking Seniors to Needed Legal Services Act of 2024, all provisions
H.R. 5526, Seniors Access to Critical Medications Act of 2024, all provisions
H.R. 9129, Patient Debt Relief Act, all provisions
Fewer Burdens for Better Care Act/draft
MACRA/MIPS program reform legislation/draft
FY 2025 Medicare physician payment increase/draft
Medical Chaperones in Medicare/draft
Medicare program: No Surprises Act implementation
Medicare program: 21st Century Cures Act implementation
Medicare program: FY 2025 Physician payment cut
Medicare program: Information Blocking Disincentives
Medicare program: Merit-based Incentive Payment System (MIPS) reform
Medicare program: Medicare Economic Index (MEI)
Medicare program: Medicare Access and CHIP Reauthorization Act (MACRA) reform
Medicare program: Budget neutrality reforms/Inflationary update
Medicare program: G2211 Inherent complexity code
Medicare program: Protecting Access to Medicare Act (PAMA 2014) lab cut reform
Medicare program: High-cost disposable services payment
Medicare program: Medicare Administrative Contractor/local-coverage determinations
Medicare program: Making Care Primary alternative payment models (APM)
Medicare program: Rural physicians APM
Medicare program: Site neutral payment
Medicare program: Physician-owned hospitals
Medicare program: Graduate Medical Education (GME) funding
Medicare program: Audio-visual supervision of residents/permanent expansion
Medicare program: Conditions of Participation (COP)/Obstetrical service
Medicare program: MACRA/physician burdens
Medicare program: Health Information Technology/physician burdens
Medicare program: Prior authorization/Medicare Advantage plans
Medicare program: Interoperability/data sharing/information blocking/provider disincentives
Medicare program: Promoting interoperability reporting
Medicare program: Trusted exchange framework/common agreement
Medicare program: Data segmentation
Medicare program: Quality payment program
Medicare program: Medicare Shared Savings Program/Advanced APM
Medicare program: Public health reporting and data exchange
Medicare program: Accountable Care Organizations/APM flexibilities
Medicare program: Certified Electronic Health Record (EHR) Technology
Medicare program: Physician Practice Information (PPI) survey/practice expense
Medicare program: MIPS Value Pathways (MVPs)/APMs
Medicare program: Telehealth flexibilities
Medicare and Medicaid programs: Data Privacy and Cybersecurity
Medicare and Medicaid programs: Health Insurance Portability and Accountability Act (HIPAA)/electronic records
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Defense - Dept of (DOD), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
George |
Cox |
III |
|
|
Ashley |
Delosh |
|
|
|
Bryan |
Hull |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Tobacco products/national tobacco cessation quitline
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 8318, Tribal Tax and Investment Reform Act of 2024, provisions relating to sections 12 and 13
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 10, VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023
H.R. 3347, Protect Lifesaving Anesthesia Care for Veterans Act of 2023, all provisions
S. 2070, Protect Lifesaving Anesthesia Care for Veterans Act of 2023, all provisions
H.R. 8371, Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act, all provisions
VA Supremacy Act
Graduate Medical Education (GME) funding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Defense - Dept of (DOD), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOR |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |